Bristol-Myers signs record biotech partnership deal
Drugmaker to pay Nektar $1.85bn upfront in hope of boosting cancer immunotherapies
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Immunotherapy | Partnerships | Pharmaceuticals